Back to STATE STREET CORP STATE STREET CORP

PTGXPTGX
28 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in PROTAGONIST THERAPEUTICS INC

Yes. State Street holds 3,321,554 shares of PTGX (Protagonist Therapeutics), worth $407.2M, as of its Q2 2026 13F filing. It increased the position by 204,805 shares (+6.6%) from Q1 2026. State Street has held PTGX in every 13F on record since Q3 2019, 28 quarterly filings.

Current Value

$407.2M

Current Shares

3.3M

Total Value Change

+$403.4M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+6.6%
$407.2M0.0%$122.58
33
2026-Q1
Decreased
3.1M
-2.6%
$328.5M0.0%$105.40
0
2025-Q4
Increased
3.2M
+1.1%
$279.5M0.0%$87.34
31
2025-Q3
Decreased
3.2M
-1.3%
$210.3M0.0%$66.43
0
2025-Q2
Increased
3.2M
+18.5%
$177.3M0.0%$55.27
36
2025-Q1
Decreased
2.7M
-18.8%
$130.9M0.0%$48.36
0
2024-Q4
Increased
3.3M
+4.6%
$128.6M0.0%$38.60
32
2024-Q3
Increased
3.2M
+52.9%
$143.3M0.0%$45.00
42
2024-Q2
Decreased
2.1M
-36.4%
$72.2M0.0%$34.65
0
2024-Q1
Increased
3.3M
+19.9%
$94.7M0.0%$28.93
35
2023-Q4
Decreased
2.7M
-30.8%
$62.6M0.0%$22.93
0
2023-Q3
Increased
3.9M
+11.0%
$65.8M0.0%$16.68
33
2023-Q2
Increased
3.6M
+47.2%
$98.1M0.0%$27.62
41
2023-Q1
Decreased
2.4M
-36.4%
$55.5M0.0%$23.00
0
2022-Q4
Decreased
3.8M
-18.9%
$41.4M0.0%$10.91
0
2022-Q3
Decreased
4.7M
-31.0%
$39.4M0.0%$8.43
0
2022-Q2
Increased
6.8M
+108.1%
$53.6M0.0%$7.91
47
2022-Q1
Increased
3.3M
+26.6%
$77.1M0.0%$23.68
37
2021-Q4
Increased
2.6M
+27.7%
$87.9M0.0%$34.20
37
2021-Q3
Increased
2M
+38.5%
$35.7M0.0%$17.72
38
2021-Q2
Decreased
1.5M
-15.1%
$65.3M0.0%$44.88
0
2021-Q1
Increased
1.7M
+15.4%
$44.4M0.0%$25.90
34
2020-Q4
Increased
1.5M
+28.6%
$29.9M0.0%$20.16
36
2020-Q3
Increased
1.2M
+201.5%
$22.6M0.0%$19.55
46
2020-Q2
Increased
382,894
+20.5%
$6.8M0.0%$17.66
32
2020-Q1
Decreased
317,792
-6.0%
$2.2M0.0%$7.06
0
2019-Q4
Increased
338,170
+7.3%
$2.4M0.0%$7.05
28
2019-Q3
First report
315,043
-
$3.8M0.0%$12.01
0

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used